Cystathionase mediates senescence evasion in melanocytes and melanoma cells

Oncogene

Volumn 33, Issue 6, 2014, Pages 771-782

  Leikam, C ^a   Hufnagel, A ^a   Walz, S ^a   Kneitz, S ^a   Fekete, A ^b   Muller M J ^b   Eilers, M ^a   Schartl, M ^a   Meierjohann, S ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

melanocyte; melanoma; ROS; transsulfuration

Indexed keywords

CELL AGING; CYSTATHIONINE GAMMA-LYASE; DNA DAMAGE; HUMANS; MELANOCYTES; MELANOMA; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84893772471     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.641     Document Type: Article

References (64)

1. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM et al. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49: 5230-5234.
2. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599-602.
3. Whitwam T, Vanbrocklin MW, Russo ME, Haak PT, Bilgili D, Resau JH et al. Differential oncogenic potential of activated RAS isoforms in melanocytes. Oncogene 2007; 26: 4563-4570.
4. Aziz N, Cherwinski H, McMahon M. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol Cell Biol 1999; 19: 1101-1115.
5. Parrella P, Caballero OL, Sidransky D, Merbs SL. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci 2001; 42: 1679-1684.
6. Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier PI, Pustelnik T, Eichler HG et al. Influence of increased c-Myc expression on the growth characteristics of human melanoma. J Invest Dermatol 1999; 112: 332-336.
7. Tulley PN, Neale M, Jackson D, Chana JS, Grover R, Cree I et al. The relation between c-myc expression and interferon sensitivity in uveal melanoma. Br J Ophthalmol 2004; 88: 1563-1567.
8. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G. c-Myc downregulation increases susceptibility to cisplatin through reactive oxygen speciesmediated apoptosis in M14 human melanoma cells. Mol Pharmacol 2001; 60: 174-182.
9. Bucci B, D'Agnano I, Amendola D, Citti A, Raza GH, Miceli R et al. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Clin Cancer Res 2005; 11: 2756-2767.
10. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA et al. C-MYC overexpression is required for continuous suppression of oncogeneinduced senescence in melanoma cells. Oncogene 2008; 27: 6623-6634.
11. Mallette FA, Gaumont-Leclerc MF, Huot G, Ferbeyre G. Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence. J Biol Chem 2007; 282: 34938-34944.
12. Herold S, Hock A, Herkert B, Berns K, Mullenders J, Beijersbergen R et al. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO J 2008; 27: 2851-2861.
13. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 2002; 10: 509-521.
14. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001; 3: 392-399.
15. Wanzel M, Herold S, Eilers M. Transcriptional repression by Myc. Trends Cell Biol 2003; 13: 146-150.
16. Leikam C, Hufnagel A, Schartl M, Meierjohann S. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 2008; 27: 7070-7082.
17. Meierjohann S, Schartl M. From Mendelian to molecular genetics: the Xiphophorus melanoma model. Trends Genet 2006; 22: 654-661.
18. Jamerson MH, Johnson MD, Dickson RB. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Oncogene 2000; 19: 1065-1071.
19. Kost DP, Michalopoulos GK. Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-ras in short-term primary hepatocyte culture. J Cell Physiol 1990; 144: 122-127.
20. Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol 2010; 12: 51-14.
21. Popov N, Schulein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of Myc by SCF(beta-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol 2010; 12: 973-981.
22. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23: 2116-2125.
23. Wanzel M, Kleine-Kohlbrecher D, Herold S, Hock A, Berns K, Park J et al. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat Cell Biol 2005; 7: 30-41.
24. Rao AM, Drake MR, Stipanuk MH. Role of the transsulfuration pathway and of gamma-cystathionase activity in the formation of cysteine and sulfate from methionine in rat hepatocytes. J Nutr 1990; 120: 837-845.
25. Jhee KH, Kruger WD. The role of cystathionine beta-synthase in homocysteine metabolism. Antioxid Redox Signal 2005; 7: 813-822.
26. Yamamoto N, Tanaka T, Noguchi T. Effect of cysteine on expression of cystathionine beta-synthase in the rat liver. J Nutr Sci Vitaminol 1995; 41: 197-205.
27. Conrad M, Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 2012; 42: 231-246.
28. Sun Q, Collins R, Huang S, Holmberg-Schiavone L, Anand GS, Tan CH et al. Structural basis for the inhibition mechanism of human cystathionine gammalyase, an enzyme responsible for the production of H(2)S. J Biol Chem 2009; 284: 3076-3085.
29. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006; 8: 1053-1063.
30. Dickhout JG, Carlisle RE, Jerome DE, Mohammed-Ali Z, Jiang H, Yang G et al. Integrated stress response modulates cellular redox state via induction of cystathionine gamma-lyase: cross-talk between integrated stress response and thiol metabolism. J Biol Chem 2012; 287: 7603-7614.
31. Fried L, Arbiser JL. The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res 2008; 21: 117-122.
32. Chintala S, Li W, Lamoreux ML, Ito S, Wakamatsu K, Sviderskaya EV et al. Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells. Proc Natl Acad Sci USA 2005; 102: 10964-10969.
33. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008; 14: 458-470.
34. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A. Deconstructing PML-induced premature senescence. EMBO J 2002; 21: 3358-3369.
35. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999; 274: 7936-7940.
36. Rai P, Young JJ, Burton DG, Giribaldi MG, Onder TT, Weinberg RA. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene 2011; 30: 1489-1496.
37. Park J, Jung Y, Kim J, Kim KY, Ahn SG, Song K et al. TC1 (C8orf4) is upregulated by cellular stress and mediates heat shock response. Biochem Biophys Res Commun 2007; 360: 447-452.
38. Li SK, Smith DK, Leung WY, Cheung AM, Lam EW, Dimri GP et al. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem 2008; 283: 16545-16553.
39. Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W et al. C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology 2008; 48: 1302-1311.
40. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475: 106-109.
41. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
42. Sankar N, Kadeppagari RK, Thimmapaya B. c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J Biol Chem 2009; 284: 15193-15205.
43. Robinson K, Asawachaicharn N, Galloway DA, Grandori C. c-Myc accelerates S-Phase and requires WRN to avoid replication stress. PLoS One 2009; 4: e5951.
44. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 2003; 17: 1569-1574.
45. Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci USA 2010; 107: 58-63.
46. Biroccio A, Amodei S, Antonelli A, Benassi B, Zupi G. Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis. J Biol Chem 2003; 278: 35693-35701.
47. Benassi B, Fanciulli M, Fiorentino F, Porrello A, Chiorino G, Loda M et al. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell 2006; 21: 509-519.
48. Benassi B, Zupi G, Biroccio A. Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells. Mol Pharmacol 2007; 72: 1015-1023.
49. van Riggelen J, Muller J, Otto T, Beuger V, YetilA, Choi PS et al. The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev 2010; 24: 1281-1294.
50. Vene R, Castellani P, Delfino L, Lucibello M, Ciriolo MR, Rubartelli A. The cystine/cysteine cycle and gsh are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets. Antioxid Redox Signal 2011; 15: 2439-2453.
51. Rosado JO, Salvador M, Bonatto D. Importance of the trans-sulfuration pathway in cancer prevention and promotion. Mol Cell Biochem 2007; 301: 1-12.
52. Yang G, Cao K, Wu L, Wang R. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem 2004; 279: 49199-49205.
53. Kandil S, Brennan L, McBean GJ. Glutathione depletion causes a JNK and p38MAPK-mediated increase in expression of cystathionine-gamma-lyase and upregulation of the transsulfuration pathway in C6 glioma cells. Neurochem Int 2010; 56: 611-619.
54. Cao Q, Zhang L, Yang G, Xu C, Wang R. Butyrate-stimulated H2S production in colon cancer cells. Antioxid Redox Signal 2010; 12: 1101-1109.
55. Rzymski T, Milani M, Singleton DC, Harris AL. Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia. Cell Cycle 2009; 8: 3838-3847.
56. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
57. Huang S, Chua JH, Yew WS, Sivaraman J, Moore PK, Tan CH et al. Site-directed mutagenesis on human cystathionine-gamma-lyase reveals insights into the modulation of H2S production. J Mol Biol 2010; 396: 708-718.
58. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935.
59. Meierjohann S, Wende E, Kraiss A, Wellbrock C, Schartl M. The oncogenic epidermal growth factor receptor variant Xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions. Cancer Res 2006; 66: 3145-3152.
60. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006; 95: 496-505.
61. Popov N, Herold S, Llamazares M, Schulein C, Eilers M. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle 2007; 6: 2327-2331.
62. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.
63. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522.
64. Kress TR, Cannell IG, Brenkman AB, Samans B, Gaestel M, Roepman P et al. The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol Cell 2011; 41: 445-457.